Author: Alan Condon

Here are six orthopedic surgeons making headlines this week:

Biopharmaceutical company DiscGenics recently finished enrollment for its clinical trial of IDCT, an allogeneic, injectable disc cell therapy for degenerative disc disease.

The Alabama Crimson Tide college football program onboarded Matt Rhea, PhD, as director of performance science on March 2, reports Sports Illustrated.

Two hospitals from College Park-based University of Maryland were recently honored by CareFirst BlueCross BlueShield for demonstrating expertise in hip and knee replacements, reports Patch.

Sioux Falls, S.D.-based Sanford Health outlined plans March 3 to build an orthopedic hospital and two clinics as part of a $209.5 million expansion over the next three years, reports the Argus Leader.

Implanet recently appointed Stephan Collardey as country manager of its German subsidiary Implanet GmbH to accelerate its commercial and business operations.

The FDA on March 3 granted Life Spine 510(k) clearance for its Lateral Prolift Expandable System.

The FlareHawk expandable cage, developed by Integrity Implants, demonstrated efficient fusion rates in a recent retrospective study.

John Abraham, MD, of Philadelphia-based Rothman Orthopaedic Institute, is now offering orthopedic oncology services at Capital Health Medical Center in Hopewell Township, N.J.

A growing number of physicians are employing medical scribes to drive efficiency and reduce administrative burdens in their practices.